Pascal Soriot – Latest stories from Nourish

a { color: #880000 !important; background: #ffeeee !important; } Latest News from NourishThe Nourish Mission (formerly OneSub)Get answers to today's big questionsWhy is Pascal Soriot in the news at the moment?

Pascal Soriot is in the news for AstraZeneca’s US expansion and stock move, highlighting UK pharma’s shifting focus under his leadership.

Stories involving Pascal Soriot

UK Pharma Investment Declines Sharply

Major pharmaceutical firms, including MSD and AstraZeneca, have announced significant cuts to UK investments, citing poor government support, undervaluation of medicines, and an uncompetitive environment. These decisions threaten the UK’s ambitions to be a global life sciences hub, with job losses and stalled projects. The government promises to act, but industry concerns persist.

Trump Secures AstraZeneca Drug Deal

On October 10, 2025, President Donald Trump announced a deal with AstraZeneca to lower drug prices for Medicaid patients by matching the lowest prices in developed countries. The agreement includes AstraZeneca's commitment to invest $50 billion in U.S. manufacturing by 2030 and participation in the upcoming TrumpRx website, which will sell discounted drugs directly to consumers starting in early 2026.